Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v6-EN
Language French English
Date Updated 2019-08-14 2019-06-25
Drug Identification Number 02240067 02240067
Brand name MYLAN-INDAPAMIDE MYLAN-INDAPAMIDE
Common or Proper name INDAPAMIDE INDAPAMIDE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients INDAPAMIDE INDAPAMIDE
Strength(s) 1.25MG 1.25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BT 100 BT
ATC code C03BA C03BA
ATC description LOW-CEILING DIURETICS, EXCL THIAZIDES LOW-CEILING DIURETICS, EXCL THIAZIDES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-05-28 2019-05-28
Actual start date 2019-05-28 2019-05-28
Estimated end date 2019-08-05
Actual end date 2019-08-13
Shortage status Resolved Actual shortage
Company comments
Health Canada comments